secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2025-02-13T23:59:59+00:00
Accession:  0001213900-25-013498
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BLAC stockholders approve business combination with OSR Holdings; name change to OSR Holdings, Inc.
--------------------------------------------------------------------------------

- All proposals approved at Feb 13 special meeting; 93.95% quorum; 57,821 shares redeemed.
- Transaction expected to close Feb 14 after foreign investment approval from Industrial Bank of Korea.
- Post-close, OSR Holdings will own ~67% of OSR; additional 22% subject to put/call from 2026.
- New tickers OSRH (common) and OSRHW (warrants) begin trading on Nasdaq Feb 18.
- Nine directors elected; portfolio includes Phase 2 immunotherapy, age-related therapies, medical device distribution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000121390025013498/0001213900-25-013498-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000121390025013498/ea0230563-8k425_bellevue.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-013498

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer